- Home
- PROK vs FJET Comparison
PROK vs FJET Comparison
Compare PROK & FJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | FJET |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.8M | 275.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | FJET |
|---|---|---|
| Price | $1.88 | $6.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.40 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $0.54 | $4.39 |
| 52 Week High | $7.13 | $28.56 |
Technical Indicators
Market Signals| Indicator | PROK | FJET |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 48.75 |
| Support Level | $1.71 | $5.94 |
| Resistance Level | $2.58 | $8.47 |
| Average True Range (ATR) | 0.12 | 0.68 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 13.89 | 60.84 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FJET Starfighters Space Inc. Common Stock
Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida. The company operates supersonic aircraft capable of sustained Mach 2 flight and configured to carry payloads to high altitudes for air launch to space. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company provides commercial space services and related aerospace capabilities.